Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Digipharm is a Swiss-based digital health company that leverages blockchain technology to facilitate value-based healthcare contracting and patient-reported outcome tracking. The company's primary solutions, 'Reimburse' and 'Insights', automate the execution of performance-based pricing agreements between health providers, payers, and pharmaceutical manufacturers. By providing a transparent and secure infrastructure for real-world evidence collection, Digipharm aims to reduce administrative burdens and ensure that healthcare payments are directly tied to patient outcomes. Their platform is designed to overcome the technical barriers to implementing complex reimbursement models in global health systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Digipharm.